Concepedia

Marianne Swanson

MS

Statistics

Publications

6

Citations

252

H-Index

6

Active since

1998

Affiliations

AstraZeneca (Sweden)(Current)

Marianne Swanson is an author at AstraZeneca (Sweden) specializing in medicine, drug discovery, and medicinal chemistry.

Top concepts

Publications per year

1998–2019

6

Publications

6

Structure−Activity Relationship of 2-[[(2-Pyridyl)methyl]thio]-1<i>H</i>- benzimidazoles as Anti<i>Helicobacter pylori</i>Agents in Vitro and Evaluation of their in Vivo Efficacy

Thomas C. Kühler, Marianne Swanson, Vladimir Shcherbuchin et al. · Journal of Medicinal Chemistry · 1998 · 75 citations

Synthesis and Pharmacological Evaluation of Novel γ-Aminobutyric Acid Type B (GABA<sub>B</sub>) Receptor Agonists as Gastroesophageal Reflux Inhibitors

Christer Alstermark, Kosrat Amin, Sean R. Dinn et al. · Journal of Medicinal Chemistry · 2008 · 48 citations · Full text

, , +15

Novel Structures Derived from 2-[[(2-Pyridyl)methyl]thio]-1<i>H</i>-benzimidazole as Anti-<i>Helicobacter </i><i>p</i><i>ylori </i>Agents, Part 1

Thomas C. Kühler, Marianne Swanson, Beritte Christenson et al. · Journal of Medicinal Chemistry · 2002 · 42 citations

Discovery of AZD6642, an Inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the Treatment of Inflammatory Diseases

Malin Lemurell, Johan Ulander, Susanne Winiwarter et al. · Journal of Medicinal Chemistry · 2014 · 38 citations

, , +18

Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease

Daniel Pettersen, Johan Broddefalk, Hans Emtenäs et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +19

Rows per page

1–5 of 6